We are live on ! Find out more
XBIT icon

XBiotech

38 hedge funds and large institutions have $14.7M invested in XBiotech in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

29% more capital invested

Capital invested by funds: $11.4M → $14.7M (+$3.29M)

12% more funds holding

Funds holding: 3438 (+4)

Holders
38
Holders Change
+4
Holders Change %
+11.76%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
16
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change

XBIT Hedge Fund Activity: Q4 2015 in Review

38 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q4 2015, worth a combined $14.7M — up 29% from $11.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new XBIT positions and 3 closed out — a net gain of 4 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.83M. The largest seller was Forest Hill Capital, exiting entirely with an estimated $672K sold.

  • 38 institutional investors held XBiotech (XBIT) as of Q4 2015, up from 34 in Q3 2015.
  • Funds reported $14.7M of XBiotech stock for Q4 2015, up 29% quarter-over-quarter.
  • 7 funds opened new XBiotech positions in Q4 2015 and 3 closed out, a net change of +4 holders.
  • The largest XBiotech buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $4.83M added.
  • The largest XBiotech seller in Q4 2015 was Forest Hill Capital, an estimated $672K sold.

Based on aggregated 13F filings for Q4 2015.